Comparison of intravitreal bevacizumab treatment between phakic and pseudophakic neovascular age-related macular degeneration.


INTRODUCTION Before the era of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment, only prevention for visual loss might have been achieved in a limited number of neovascular age-related macular generation (nAMD) patients with different treatment options. OBJECTIVE To compare the efficacy of intravitreal bevacizumab (IVB) for the… (More)
DOI: 10.3126/nepjoph.v6i2.11706


2 Figures and Tables

Slides referencing similar topics